Showing results (1561-1570 of 1,576) with videos related to

Sort By:
Pageof 158
Stem Cells and Development|December 6, 2013
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translationDavid A Brindley, Anna French, Jane Suh, et al.
Nature Communications|April 26, 2018
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for diseaseConnor A Emdin, Amit V Khera, Mark Chaffin, et al.
Nature|September 25, 2023
Distinguishing features of long COVID identified through immune profilingJon Klein, Jamie Wood, Jillian R Jaycox, et al.
The Lancet. Neurology|February 21, 2026
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USAEric M Reiman, Robert C Alexander, Jessica B Langbaum, et al.
Journal of the American College of Cardiology|April 21, 2020
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art ReviewBehnood Bikdeli, Mahesh V Madhavan, David Jimenez, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
JAMA Neurology|March 4, 2024
Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019Daniela Renedo, Julian N Acosta, Audrey C Leasure, et al.
Thrombosis and Haemostasis|May 31, 2020
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future ResearchBehnood Bikdeli, Mahesh V Madhavan, Aakriti Gupta, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Pageof 158